Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2.
Linkage analysis was performed on a large pedigree with an autosomal dominant platelet disorder and a striking propensity in affected family members to develop hematologic malignancy, predominantly acute myelogenous leukemia. We report the linkage of the autosomal dominant platelet disorder to markers on chromosome 21q22. Four genetic markers completely cosegregate with the trait and yield maximum logarithm of difference scores ranging from 4.9 to 10.5 (theta = .001). Two flanking markers, D21S1265 and D21S167, define a critical region for the disease locus of 15.2 centimorgan. Further analysis of this locus may identify a gene product that affects platelet production and function and contributes to the molecular evolution of hematologic malignancy.
Ho
C Y
CY
Department of Medicine, Division of Hematology/Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Otterud
B
B
Legare
R D
RD
Varvil
T
T
Saxena
R
R
DeHart
D B
DB
Kohler
S E
SE
Aster
J C
JC
Dowton
S B
SB
Li
F P
FP
Leppert
M
M
Gilliland
D G
DG
D000208:Acute Disease; D000328:Adult; D001791:Blood Platelet Disorders / Q000235:genetics*; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D004198:Disease Susceptibility; D005260:Female; D005799:Genes, Dominant; D005819:Genetic Markers; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D007951:Leukemia, Myeloid / Q000235:genetics*; D008126:Lod Score; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D009857:Oncogenes; D010375:Pedigree
D005819:Genetic Markers